Management of Patients With Suspected of Sleep Apnea-hypopnea Syndrome

Status Completed

Clinical Trial Summary

Obstructive sleep apnea syndrome (OSA) is characterized by the manifestation of excessive sleepiness secondary to repeated obstruction of the upper airway during sleep and cognitive-behavioral, respiratory, cardiac, metabolic or inflammatory disorders. Epidemiological studies in our country have shown that OSA is a highly prevalent disease in the general population, affecting 2-4% of the adult population. The most important clinical manifestations of OSAS is a deterioration in the quality of life and an increase in cardiovascular disease. OSA is also associated with traffic accidents. Therefore, and considering the medical complications of OSA, as well as the sociolaboral impact and its negative impact on quality of life and survival; is stated that this disease is a public health problem that requires the physician to identify patients eligible to treatment. Moreover, it has been shown that undiagnosed patients, duplicate the consumption of health resources, comparing when the diagnosis and treatment has been established. Finally, we have a highly effective treatment using positive pressure in the upper airway (CPAP) that has been shown to be effective and cost-effective. The current situation in which all patients diagnosed with OSA and receiving different treatments are monitored and controlled by the Sleep Units (SU) is an oversized medicine specialist at the expense of primary care (PC). Our working hypothesis is: "By the coordination of actions at various levels including interactive training equipment AP, use the bilateral (SU-AP) of electronic medical records and the use of new technologies can be achieved in AP satisfactory management of the diagnostic and therapeutic process of patients with suspected OSA. Patients assisted in both areas have a level of clinical response, satisfaction, compliance and avoidance of complications, similar to that obtained with monitoring by SU. In addition, management by AP will be more cost-effective than in the SU."

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02234765
Study type	Interventional
Source	Sociedad Española de Neumología y Cirugía Torácica
Contact
Status	Completed
Phase	N/A
Start date	May 2014
Completion date	May 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02916160` - Sacubitril-valsartan and Heart Failure Patients : the ENTRESTO-SAS Study	Phase 4
Active, not recruiting	`NCT00746928` - Cardiovascular Consequences of Intermittent Hypoxia in Healthy Subjects	N/A
Terminated	`NCT00816829` - Effect of Fenofibrate on Sleep Apnea Syndrome	Phase 2
Recruiting	`NCT00152711` - Impact of nCPAP Treatment on Liver Function in Patients With Sleep Apnea Syndrome and Nonalcoholic Steatohepatitis	N/A
Completed	`NCT02482480` - Comprehensive Management for the Treatment of Obstructive Sleep Apnea	N/A
Recruiting	`NCT02408172` - Effects of Metoprolol and Amlodipine on Cardiac Remodeling, Arrhythmias and Blood Pressure Variation in Hypertensive Patients With Sleep Apnea Syndrome	Phase 2/Phase 3
Terminated	`NCT01354756` - Validation of Apnea LinkTM for Sleep Apnea Syndrome Screening in a Bariatric Population	N/A
Terminated	`NCT01196845` - Inflammation and Oxidative Stress of Adipose Tissue in Sleep Apnea Syndrome	N/A
Completed	`NCT03116958` - MyOSA : Management and Treatment of Patients With Obstructive Sleep Apnea Syndrome(OSAS) Through a Telemedicine System	N/A
Terminated	`NCT02649933` - Detection of Sleep Apnea Syndrome (OSA) in Pregnant Women and Assessment of Impact of OSA on Pregnancy Course	N/A
Completed	`NCT02789696` - Prevalence of Acromegaly in a Diagnostic Consultation for Sleep Apnea Syndrome	N/A
Completed	`NCT01164631` - Pharyngeal Size in Patients With Obstructive Tonsils Under Orthodontic Treatment	Phase 4
Completed	`NCT00317083` - Cough Reflex and Obstructive Sleep Apnea Syndrome	N/A
Completed	`NCT02893865` - Evolution of Oxidative Stress in Coronary Patients With Moderate Sleep Apnea Syndrome After Treatment With Continuous Positive Airway Pressure	N/A
Completed	`NCT01752556` - Cost-effectiveness of Home Respiratory Polygraphy	Phase 3
Completed	`NCT00001723` - Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases	Phase 2
Completed	`NCT02148432` - Establishment of Ideal IV Sedative Regimen for Successful Fiberoptic Bronchoscopy in Assessing the Site, Severity of Sleep Apnea Syndrome	N/A
Completed	`NCT02657304` - Effect of Early Education on the Observance of CPAP Treatment	N/A
Completed	`NCT02591979` - PASHOS Project: Advanced Platform for Sleep Apnea Syndrome Assessment
Recruiting	`NCT00936273` - Sleep Apnea and Periodic Breathing	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Management of Patients With Suspected of Sleep Apnea-hypopnea Syndrome From Primary Care — GESAP

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms